Hospira has initiated a voluntary recall of one lot of its injectable magnesium sulfate solution because of incorrect barcode labeling on the product container.
The recalled lot was distributed nationwide from September 2015 to November 2015. Hospira has not reported any adverse events and has begun an investigation to determine cause of the labeling error. The product is packaged in 50- and 100-mL container bags.
A spokesman for Pfizer — which purchased Hospira in September — did not return a call for comment by press time.